Alpha DNA Investment Management’s National Vision EYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5
Closed 284
2021
Q1
$0 Sell
5
-17,116
-100% -$816K ﹤0.01% 718
2020
Q4
$775K Buy
+17,121
New +$744K 0.83% 47

Other funds holding EYE

Alpha DNA Investment Management's EYE Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of National Vision (EYE) in Q2 2021, closing a stake of 5 shares.

Alpha DNA Investment Management first reported a position in EYE in Q4 2020 and held it in 2 quarters. The position peaked at $775K in Q4 2020. 193 funds tracked by Wall St. Rank hold EYE as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining National Vision position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5 National Vision shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in National Vision in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's National Vision position peaked at $775K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held National Vision as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.